Profil Pasien Kanker Ovarium yang Dilakukan Fertility Sparing Surgery di RSUP Dr. Hasan Sadikin Bandung Tahun 2017-2020

Rania Ramadha Athiyazahra,(1*) Ali Budi Harsono,(2) Hartanto Bayuaji,(3)

(2) Dep/KSM Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran/RS Hasan Sadikin, Bandung
(3) Dep/KSM Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran/RS Hasan Sadikin, Bandung
(*) Corresponding Author


Tujuan: Tujuan penelitian ini untuk menggambarkan karakteristik pasien kanker ovarium yang dilakukan tindakan fertility sparing surgery.
Metode: Penelitian deskriptif menggunakan data rekam medis pasien kanker ovarium yang dilakukan tindakan fertility sparing surgery di RSUP Dr. Hasan Sadikin Bandung pada tahun 2017-2020. Sampel yang digunakan sebanyak 35 data rekam medis menggunakan metode total sampling.
Hasil: Dari 35 pasien, sebagian besar berusia 20-29 tahun (37%),belum menikah (54%), dan nulipara (71%), Tindakan fertility sparing surgery dilakukan pada stadium I-II untuk tipe sel epitel, stadium I-III untuk tipe sel germinal, dan hanya pada stadium I untuk tipe sel sex cord stromal. Pasien usia <20 tahun dilakukan tindakan fertility sparing surgery pada stadium III dengan jenis histopatologi tipe sel germinal sementara pasien dengan usia>20 tahun mayoritas dilakukan tindakan pada stadium I dengan tipe histopatologi terbanyak adalah tipe sel epitel.
Kesimpulan: Tindakan fertility sparing surgery bertujuan untuk mempertahankan organ reproduksi. Karakteristik pasien kanker ovarium yang dapat dilakukan tindakan fertility sparing surgery berusia 20-29 tahun dan nulipara. Tindakan fertility sparing surgery pada tipe sel epitel dan tipe sex cord stromal hanya dilakukan pada stadium dini, sementara pada tipe sel germinal dapat dilakukan hingga stadium III.

Ovarian Cancer Patient Profile Undergoing Fertility Sparing Surgery at
Dr. Hasan Sadikin General Hospital Bandung From 2017 Until 2020

Objective: Aimed to describe the characteristics of ovarian cancer patients underwent fertility sparing surgery between 2017-2020 at Dr. Hasan Sadikin General Hospital Bandung.
Methods: A descriptive study that used medical records of ovarian cancer patients that underwent fertility sparing surgery at Dr. Hasan Sadikin General Hospital from 2017-2020. The sample used was 35 data, using the total sampling methods.
Result: From a total of 35 patients, most were aged 20-29 years (37%), unmarried (54%), and nulliparous (71%). Fertility sparing surgery was performed at stage I-II for epithelial cell, stage I-III for germ cells, and stage I for sex-cord stromal cells. Patients <20 years underwent fertility sparing surgery at stage III with the most common histopathology type is germ cell while patients >20 years underwent fertility sparing surgery at stage I with the histopathology type is surface epithelial cells.
Conclusion: Fertility sparing surgery aimed to maintain the reproductive organs. Characteristics of patients who underwent fertility sparing surgery are aged 20-29 years and nulliparous. Fertility sparing surgery can be performed at an early stage for epithelial cell and sex-cord stromal cells, while germ cell can be performed up to stage III.

Key words: ovarian cancer, fertility sparing surgery, characteristics


kanker ovarium, konservatif surgical staging, karakteritsik

Full Text:



Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today: International Agency for Research on Cancer (IARC) 2020 [Available from:

Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287-99.

Handa VL, Van Le l. Te Linde’s Operative Gynecology,12th Edition. Lippincott Williams & Wilkins; 2019. p. 763-73.

Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9-32.

Iversen L, Fielding S, Lidegaard O, Morch LS, Skovlund CW, Hannaford PC. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ. 2018;362:k3609.

Thomakos N, Malakasis A, Machairiotis N, Zarogoulidis P, Rodolakis A. Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome? J Cancer. 2018;9(24):4659-64.

Mandelbaum RS, Klar M, Takiuchi T, Bainvoll L, Matsuzaki S, Paulson RJ, et al. Fertility-sparing treatment for early-stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives. J Obstet Gynaecol Res. 2020;46(8):1263-81.

Canlorbe G, Chabbert-Buffet N, Uzan C. Fertility-Sparing Surgery for Ovarian Cancer. J Clin Med. 2021;10(18).

Kawasaki A, Shikama A, Tsaka N, Akiyama A, Sakurai M, Ochi H, et al. Evaluation of the ovarian reserve after fertility-sparingsurgery for ovarian malignancy by measuring the level of serum anti-Müllerian hormone. Journal Pregnancy Reprod. 2018;2(4):3-4.

Johansen G, Dahm-Kahler P, Staf C, Floter Radestad A, Rodriguez-Wallberg KA. A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women. BMC Cancer. 2020;20(1):1009.

Schuurman T, Zilver S, Samuels S, Schats W, Amant F, van Trommel N, et al. Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review. Cancers. 2021;13(5):1008.

Berek JS, Kehoe ST, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2018;143 Suppl 2:59-78.

Horvath LE, Werner T, Boucher K, Jones K. The relationship between tumor size and stage in early versus advanced ovarian cancer. Med Hypotheses. 2013;80(5):684-7.

Noela F, Nuryanto KH. Epidemiology Data of Ovarian Cancer in Dr. Cipto Mangunkusumo Hospital, Jakarta. Indonesian Journal Obstetric Gynecology Science. 2016;4(2).

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284-96.

Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, et al. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol. 2017;130(1):71-9.

Chaopotong P, Therasakvichya S, Leelapatanadit C, Jaishuen A, Kuljarusnont S. Ovarian Cancer in Children and Adolescents: Treatment and Reproductive Outcomes. Asian Pac J Cancer Prev. 2015;16(11):4787-90.

Bentivegna E, Gouy S, Maulard A, Pautier P, Leary A, Colombo N, et al. Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues. Ann Oncol. 2016;27(11):1994-2004.



  • There are currently no refbacks.


Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat